Vistaril and Mometasone furoate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vistaril (hydroxyzine hydrochloride) and Mometasone furoate (mometasone furoate). Common drug interactions include infection among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Vistaril and Mometasone furoate. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Vistaril?

Vistaril has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 9,565 Vistaril users. Check the latest studies of Vistaril.

What is Mometasone furoate?

Mometasone furoate has active ingredients of mometasone furoate. It is often used in allergies. eHealthMe is studying from 11,728 Mometasone furoate users. Check the latest studies of Mometasone furoate.



On Jul, 16, 2026

30 people who take Vistaril and Mometasone furoate together, and have interactions are studied.

Vistaril and Mometasone furoate drug interactions.

What are the common drug interactions of Vistaril and Mometasone Furoate, by gender? *:

female:

  1. Infection
  2. Sinusitis (inflammation of sinus)
  3. Arthralgia (joint pain)
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Cough
  6. Fall
  7. Fatigue (feeling of tiredness)
  8. Pneumonia
  9. Spinal disorder (disease of spine a back bone)
  10. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

  1. Decreased appetite
  2. Ear infection
  3. White blood cell count decreased
  4. Ear infection fungal
  5. Infusion site bruising
  6. Infusion site swelling
  7. Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
  8. Sinusitis (inflammation of sinus)
  9. Sinusitis bacterial (bacterial infection of sinus)
  10. Staphylococcal infection (an infection with staphylococcus bacteria)

What are the common drug interactions of Vistaril and Mometasone Furoate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Decreased appetite
  2. Ear infection
  3. Ear infection fungal
  4. Infusion site bruising
  5. Infusion site swelling
  6. Injection site vesicles (fluid- or air-filled cavity or sac at injection site)
  7. Sinusitis (inflammation of sinus)
  8. Sinusitis bacterial (bacterial infection of sinus)
  9. Staphylococcal infection (an infection with staphylococcus bacteria)
  10. Weight decreased

30-39:

n/a

40-49:

n/a

50-59:

  1. Chronic kidney disease
  2. Depression
  3. Nephrogenic anaemia (anaemia due to kidney disease)
  4. Renal failure (kidney dysfunction)
  5. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  6. Injury
  7. Psoriasis (immune-mediated disease that affects the skin)
  8. Renal tubular necrosis (death of kidney tubules)

60+:

  1. Arthralgia (joint pain)
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Immune system disorder
  4. Infection
  5. Infusion site discomfort
  6. Infusion site swelling
  7. Pain
  8. Sinusitis (inflammation of sinus)
  9. Swelling
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 17 people, 56.67%
  2. Hypergammaglobulinaemia (elevated levels of gamma globulin): 9 people, 30.00%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 16.67%
  4. Immune System Disorder: 4 people, 13.33%
  5. Endometrial Cancer: 4 people, 13.33%
  6. Neuropathy Peripheral (surface nerve damage): 3 people, 10.00%
  7. Gastric Ph Decreased: 3 people, 10.00%
  8. High Blood Cholesterol: 3 people, 10.00%
  9. Colitis (inflammation of colon): 2 people, 6.67%
  10. Constipation: 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Vistaril and Mometasone furoate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Vistaril and Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Vistaril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Mometasone furoate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vistaril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mometasone furoate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on hydroxyzine hydrochloride and mometasone furoate (the active ingredients of Vistaril and Mometasone furoate, respectively), and Vistaril and Mometasone furoate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: